NASE:BAT Statistics

Total Valuation

NASE:BAT has a market cap or net worth of KES 34.68 billion. The enterprise value is 29.38 billion.

Market Cap	34.68B
Enterprise Value	29.38B

Important Dates

The next estimated earnings date is Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	May 26, 2025

Share Statistics

NASE:BAT has 100.00 million shares outstanding.

Current Share Class	100.00M
Shares Outstanding	100.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	1.02%
Float	40.00M

Valuation Ratios

The trailing PE ratio is 7.73.

PE Ratio	7.73
Forward PE	n/a
PS Ratio	1.35
PB Ratio	2.20
P/TBV Ratio	2.20
P/FCF Ratio	4.59
P/OCF Ratio	4.40
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.34, with an EV/FCF ratio of 3.89.

EV / Earnings	6.55
EV / Sales	1.14
EV / EBITDA	3.34
EV / EBIT	3.63
EV / FCF	3.89

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.01.

Current Ratio	2.26
Quick Ratio	1.63
Debt / Equity	0.01
Debt / EBITDA	0.01
Debt / FCF	0.01
Interest Coverage	65.80

Financial Efficiency

Return on equity (ROE) is 28.04% and return on invested capital (ROIC) is 31.52%.

Return on Equity (ROE)	28.04%
Return on Assets (ROA)	21.21%
Return on Invested Capital (ROIC)	31.52%
Return on Capital Employed (ROCE)	45.92%
Revenue Per Employee	66.11M
Profits Per Employee	11.53M
Employee Count	389
Asset Turnover	1.08
Inventory Turnover	3.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.07% in the last 52 weeks. The beta is 0.05, so NASE:BAT's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-5.07%
50-Day Moving Average	371.65
200-Day Moving Average	360.42
Relative Strength Index (RSI)	30.53
Average Volume (20 Days)	18,180

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NASE:BAT had revenue of KES 25.72 billion and earned 4.48 billion in profits. Earnings per share was 44.83.

Revenue	25.72B
Gross Profit	10.71B
Operating Income	8.09B
Pretax Income	6.48B
Net Income	4.48B
EBITDA	8.77B
EBIT	8.09B
Earnings Per Share (EPS)	44.83

Full Income Statement

Balance Sheet

The company has 5.39 billion in cash and 97.67 million in debt, giving a net cash position of 5.29 billion or 52.93 per share.

Cash & Cash Equivalents	5.39B
Total Debt	97.67M
Net Cash	5.29B
Net Cash Per Share	52.93
Equity (Book Value)	15.73B
Book Value Per Share	157.33
Working Capital	7.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.88 billion and capital expenditures -322.02 million, giving a free cash flow of 7.56 billion.

Operating Cash Flow	7.88B
Capital Expenditures	-322.02M
Free Cash Flow	7.56B
FCF Per Share	75.56

Full Cash Flow Statement

Margins

Gross margin is 41.64%, with operating and profit margins of 31.48% and 17.43%.

Gross Margin	41.64%
Operating Margin	31.48%
Pretax Margin	25.21%
Profit Margin	17.43%
EBITDA Margin	34.09%
EBIT Margin	31.48%
FCF Margin	29.38%

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 14.42%.

Dividend Per Share	50.00
Dividend Yield	14.42%
Dividend Growth (YoY)	11.11%
Years of Dividend Growth	n/a
Payout Ratio	111.52%
Buyback Yield	n/a
Shareholder Yield	14.42%
Earnings Yield	12.93%
FCF Yield	21.79%

Dividend Details

Stock Splits

The last stock split was on March 13, 2000. It was a forward split with a ratio of 1.33333.

Last Split Date	Mar 13, 2000
Split Type	Forward
Split Ratio	1.33333

Scores

NASE:BAT has an Altman Z-Score of 6.17.

Altman Z-Score	6.17
Piotroski F-Score	n/a